Stock Movers Burberry Gains, Merck Up, Siemens Falls
Nov 13, 2025
Chloe Millais, a Bloomberg reporter specializing in market commentary, dives into the significant stock movements of Burberry, Merck, and Siemens. She highlights Burberry's impressive turnaround, attributed to strong retail sales and strategic cost cuts. Merck shines with an 8.6% surge, thanks to a robust performance in its tumor drugs and life sciences division. Meanwhile, Siemens faces challenges with currency headwinds dampening growth forecasts and costs from recent acquisitions. Tune in for insights on these market shifts!
AI Snips
Chapters
Transcript
Episode notes
Burberry's Turnaround Pays Off
- Burberry returned to retail sales growth for the first time in two years driven by strong demand in China and a refocus on classic products.
- CEO strategy and cost cuts, including shedding about 20% of staff, improved execution and investor confidence.
Refocus On Core Products
- Focus on core strengths can reverse brand missteps, as Burberry did by returning to trench coats and scarves.
- Combine product refocus with disciplined cost cuts to improve margins and investor trust.
Merck Boosted By New Drugs And Equipment Demand
- Merck beat estimates thanks to strong sales of new tumor drugs and a rebound in its life sciences equipment business.
- Acquisitions like Springworks and cost controls also contributed to the stronger quarter.